Wild-Type RAS, HER2-Positive Colorectal Cancer
Colorectal cancer (CRC) is a biologically diverse malignancy characterized by distinct molecular profiles. One such molecular subtype includes tumors that are wild-type RAS (lacking mutations in KRAS and NRAS) and HER2-positive, representing a unique and actionable subgroup. HER2 (human epidermal growth factor receptor 2) overexpression or amplification, traditionally associated with breast and gastric cancers, has